Interferon, kappa (IFNK) (C-Term) Peptide
IFNK
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all IFNK products
- IFNK (Interferon, kappa (IFNK))
- Protein Region
- C-Term
- Origin
- Human
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- MKPSEARVPQ LSSLELRRYF HRIDNFLKEK KYSDCAWEIV RVEIRRCLYY
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-IFNK Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- IFNK (Interferon, kappa (IFNK))
- Synonyms
- IFNK Peptide, IFNT1 Peptide, INFE1 Peptide, RP11-27J8.1 Peptide, interferon kappa Peptide, IFNK Peptide, Ifnk Peptide
- Background
-
This gene encodes a member of the type I interferon family. Type I interferons are a group of related glycoproteins that play an important role in host defenses against viral infections. This protein is expressed in keratinocytes and the gene is found on chromosome 9, adjacent to the type I interferon cluster.
Alias Symbols: RP11-27J8.1
Protein Size: 207 - Molecular Weight
- 22 kDa
- Gene ID
- 56832
- NCBI Accession
- NM_020124, NP_064509
- UniProt
- Q9P0W0
-
You are here:
